We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Absology

ABSOLOGY is a medical equipment manufacturer that develops and mass-produces in vitro diagnostic medical devices. ABS... read more Featured Products: More products

Download Mobile App





Absology Showcases Latest Advancements in Medical Diagnostics

By LabMedica International staff writers
Posted on 15 Nov 2023

Absology Co. More...

, Ltd. (Gyeonggi-do, Korea) is showcasing its POCT innovations at MEDICA 2023 that empower healthcare providers to deliver rapid, accurate diagnostic information at the patient's bedside. Absology is also highlighting its latest innovations in cardiac markers, infectious diseases, endocrine, urology, metabolism, and inflammation testing for humans and companion animals.

At MEDICA 2023, Absology is highlighting the ABSOL automated fluorescent immunoassay (FIA) analyzer. Designed for POCT near the patient testing device, it provides quantitative results based on immunoassay technology. The Absoludy cartridges utilize microfluidics lateral flow technology where the analyte of interest in the sample forms immune complexes while moving through the pathway in the cartridges. Inside ABSOL Analyzer, a built-in on/off valve system can actively control the flow of specimens to ensure reliable test results.

Absology is also highlighting its groundbreaking approach to Alzheimer's diagnosis with ABSOL HS. The cutting-edge POCT device, developed by ABSOLOGY's expert researchers, utilizes Photo oxidation-induced fluorescence amplification (PIFA) technology for unmatched sensitivity. It can detect Alzheimer's in its early stages, ensuring timely interventions and improved patient outcomes. Plus, ABSOL HS seamlessly integrates into the laboratory workflow, making disease detection hassle-free.

Related Links:
Absology Co., Ltd. 


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
PlGF Test
Quidel Triage PlGF Test
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.